Security key
58470H101
MEDIFAST INC - Common Stock, par value $0.001 per share (the "Shares") (MED)
CUSIP: 58470H101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share (the "Shares")
- Shares outstanding
- 11,014,000
- Total 13F shares
- 8,622,468
- Share change
- +383,233
- Total reported value
- $121,151,406
- Put/Call ratio
- 7.6%
- Price per share
- $14.05
- Number of holders
- 119
- Value change
- +$5,639,293
- Number of buys
- 66
- Number of sells
- 55
Report period
Q2 2025
Institutions
119
Top holders
10
MED full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
MEDIFAST INC SEC filings
MEDIFAST INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 58470H101
Recent filing periods:
Top shareholders of MED - MEDIFAST INC - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
8.6%
|
950,053
|
$12,806,715 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
8.1%
|
888,928
|
$11,982,749 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
773,649
|
$10,428,790 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.5%
|
385,723
|
$5,193,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3%
|
333,446
|
$4,494,852 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.7%
|
293,561
|
$3,957,219 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.6%
|
288,515
|
$3,889,179 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.4%
|
265,572
|
$3,579,911 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
256,483
|
$3,458,390 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2%
|
224,945
|
$3,032,259 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
223,781
|
$3,016,568 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2%
|
219,000
|
$2,952,120 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2%
|
216,723
|
$2,921,426 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
199,750
|
$2,692,630 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
1.8%
|
196,956
|
$2,654,967 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
184,248
|
$2,483,823 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.6%
|
175,770
|
$2,369,379 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
172,238
|
$2,321,768 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.5%
|
166,199
|
$2,240,362 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.3%
|
143,027
|
$1,928,004 | — | 31 Mar 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
1.1%
|
122,172
|
$1,646,879 | — | 31 Mar 2025 | |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1%
|
110,000
|
$1,482,800 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
96,890
|
$1,306,077 | — | 31 Mar 2025 | |
| Virtus Family Office LLC |
13F
|
Company |
0.7%
|
76,746
|
$1,034,536 | — | 31 Mar 2025 | |
| Kevin G. Byrnes |
3/4/5
|
Director |
—
class O/S missing
|
14,922
|
$1,027,977 | — | 11 Nov 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.64%
|
70,479
|
$950,057 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.63%
|
69,200
|
$932,816 | — | 31 Mar 2025 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.6%
|
66,470
|
$896,016 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
66,196
|
$892,322 | — | 31 Mar 2025 | |
| Values First Advisors, Inc. |
13F
|
Company |
0.58%
|
64,228
|
$868,540 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.51%
|
56,662
|
$763,804 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
52,025
|
$701,297 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.45%
|
49,021
|
$660,803 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.44%
|
48,797
|
$657,780 | — | 31 Mar 2025 | |
| Jeffrey J. Brown |
3/4/5
|
Director |
0.39%
|
42,811
|
$573,487 | — | 25 Jun 2025 | |
| SummerHaven Investment Management, LLC |
13F
|
Company |
0.38%
|
42,073
|
$567,144 | — | 31 Mar 2025 | |
| COMMONS CAPITAL, LLC |
13F
|
Company |
0.35%
|
38,000
|
$512,240 | — | 31 Mar 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.32%
|
35,563
|
$479,387 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.32%
|
35,537
|
$479,039 | — | 31 Mar 2025 | |
| State of Wyoming |
13F
|
Company |
0.29%
|
32,137
|
$433,207 | — | 31 Mar 2025 | |
| Ming Xian |
3/4/5
|
Director |
—
class O/S missing
|
32,143
|
$430,393 | — | 25 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.27%
|
30,185
|
$406,894 | — | 31 Mar 2025 | |
| Amundi |
13F
|
Individual |
0.28%
|
30,439
|
$397,533 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.25%
|
27,906
|
$376,173 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.25%
|
27,501
|
$370,710 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.24%
|
26,720
|
$360,186 | — | 31 Mar 2025 | |
| Michael A. Hoer |
3/4/5
|
Director |
0.24%
|
26,139
|
$351,575 | — | 25 Jun 2025 | |
| BENJAMIN EDWARDS INC |
13F
|
Company |
0.22%
|
24,419
|
$329,168 | — | 31 Mar 2025 | |
| Andrea B. Thomas |
3/4/5
|
Director |
0.22%
|
24,017
|
$323,030 | — | 25 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
21,900
|
$295,212 | — | 31 Mar 2025 |
Institutional Holders of MEDIFAST INC - Common Stock, par value $0.001 per share (the "Shares") (MED) as of Q2 2025
As of 30 Jun 2025,
MEDIFAST INC - Common Stock, par value $0.001 per share (the "Shares") (MED) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,622,468 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
122
Q2 2025 holders
119
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.